B
Bull
Bull · 25%ZYXI
$2.25
シナリオ価格
$0.125
-0.044 (-34.90%)終値時点
Loading chart…
- High
- 0.200
- Open
- 0.200
- VWAP
- 0.15
- Vol
- 32.29M
- Mkt Cap
- 286.93M
- Low
- 0.125
- Amount
- 4.84M
- EV/EBITDA, TTM
- 8.55
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Analyst Ratings (1)
Buy
1 Buy
0 Hold
0 Sell
Current: 0.13
安値
3.70
平均
—
高値
3.70
H.C. Wainwright
Neutral
—
2025-08-01
H.C. Wainwright
2025-08-01
目標株価
—
Neutral
Ladenburg
Buy
$3.70
2025-08-01
Ladenburg
2025-08-01
目標株価
$3.70
Buy
RBC Capital
Sector Perform
$3
2025-07-15
RBC Capital
2025-07-15
目標株価
$3
Sector Perform
HC Wainwright & Co.
Strong Buy
$15
2025-03-12
HC Wainwright & Co.
2025-03-12
目標株価
$15
Strong Buy
Ladenburg Thalmann
Hold
—
2025-03-12
Ladenburg Thalmann
2025-03-12
目標株価
—
Hold
バリュエーション指標
The current forward P/E ratio for Zynex Inc (ZYXI) is 15.04, compared to its 5-year average forward P/E of 19.21.
Alphio AI Price Scenarios for ZYXI
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
イベントタイムライン
ニュース
7.007-21PRnewswireZynex Faces Investigation for Misleading Investors
7.007-21NewsfilterZynex, Inc. Under Investigation for Shareholder Lawsuit
9.003-27GlobenewswireZynex Faces Class Action Lawsuit Over Fraud Allegations
9.003-25GlobenewswireZynex Faces Securities Class Action Lawsuit Following Bankruptcy
9.003-17GlobenewswireZynex Faces Securities Class Action Lawsuit Following Bankruptcy
ZYXI FAQ — answered by Alphio AI
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
1 analysts cover ZYXI: 1 rate it Buy, 0 Hold and 0 Sell.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。